Elsevier

Analytical Biochemistry

Volume 197, Issue 1, 15 August 1991, Pages 77-82
Analytical Biochemistry

The identification of trimethylamine excess in man: Quantitative analysis and biochemical origins

https://doi.org/10.1016/0003-2697(91)90358-ZGet rights and content

Abstract

The underlying biochemical causes of chronic odor problems in humans have attracted only a few investigators. This may be due, in part, to intermittent odor complaints, to the psychological problems often associated with these patients, or to the low incidence of a true metabolic disorder. One cause of intense odor is an excessive excretion of trimethylamine (TMA) in sweat, breath, and urine and was reported to be due to a defect in the liver enzyme that converts this volatile amine to its N-oxide. Other investigators have reported TMA excess as a result of liver, kidney, and/or gastrointestinal dysfunction. We report on the development of an analytical technique for urine that can be used to identify those individuals whose chronic odor is caused by a defect in their TMA pathway. A simple extension of the basic TMA analysis can be used to measure the concentration of TMA N-oxide in the affected patients. These data can, in turn, be used to demonstrate the level of activity of the N-oxide-forming enzyme in these subjects. The results obtained from using this test on more than 50 subjects indicate, in addition to a normal population, at least two types of patients with TMA excess. One group has excess TMA excretion with low activity of the N-oxide and another group shows excess TMA excretion with normal N-oxide activity.

References (22)

  • J.R. Humbert et al.

    Lancet

    (1970)
  • T. Higgins et al.

    Biochem. Med

    (1972)
  • G.D. Calvert

    Lancet

    (1973)
  • M.L. Simenhoff et al.

    Lancet

    (1976)
  • G.R. Fenwick et al.

    Lancet

    (1983)
  • R. Marks et al.

    Lancet

    (1978)
  • A.M. Asatoor et al.

    Biochim. Biophys. Acta

    (1965)
  • P. Schlesinger

    Anal. Biochem

    (1979)
  • M.A. Brewster et al.

    Ann. Clin. Lab Sci

    (1983)
  • D.M. Danks et al.

    N. Engl. J. Med

    (1976)
  • H.K. Schedewie et al.

    Clin. Res

    (1980)
  • Cited by (49)

    • Effects of IGZO film thickness on H<inf>2</inf>S gas sensing performance: Response, excessive recovery, low-frequency noise, and signal-to-noise ratio

      2021, Sensors and Actuators, B: Chemical
      Citation Excerpt :

      Gas sensor technologies have been applied to the various aspects of our daily life and their applications range from industrial manufacturing environment monitoring [1–3] and medical diagnostics [4–6] to indoor air quality monitoring [7–9].

    • Acetone sensing of Au and Pd-decorated WO<inf>3</inf> nanorod sensors

      2015, Sensors and Actuators, B: Chemical
      Citation Excerpt :

      In this study, Pd/Au bimetallic nanoparticles were synthesized by immersing tungsten trioxide (WO3) nanorods in an acetone/HAuCl4/PdCl2 solution followed by UV irradiation and annealing. Acetone (CH3COCH3) is a good breath marker for the non-invasive diagnosis of diabetes [17,18]. Metal-oxide semiconductor gas sensors offer advantages in the detection of acetone gas, such as higher sensitivity, smaller size, lower cost, simpler operation, and better reversibility [19–21] compared to the techniques commonly used for detecting acetone, such as gas chromatography and mass spectrometry [22,23].

    • Systems biochemical responses of rats to Kansui and vinegar-processed Kansui exposure by integrated metabonomics

      2014, Journal of Ethnopharmacology
      Citation Excerpt :

      Decreases in hepatic taurine concentrations were remarkable in liver extracts from Kansui and VP-Kansui-treated rats, which could be attributed to increased excretion of taurine-conjugated bile acids caused by excess liver cholesterol accumulation (Rull et al., 2009). With Kansui treatment, choline and phosphocholine (Tjoa and Fennessey, 1991; Zeisel et al., 1983), both products of lipid catabolism, were elevated in liver and lowered in kidney, changes that could be evidence of lipid metabolic disturbances in Kansui-treated rats. Notably, choline and phosphocholine decreased in kidney because this organ, unlike liver, does not intrinsically control lipid levels.

    View all citing articles on Scopus
    View full text